Tag: alzheimer’s,
Light Therapy for Alzheimer’s: Shining a Light on Hope!
BBC presenter Susan Rae thanks listeners for support after Alzheimer’s diagnosis
Ditching popular food could stave off Alzheimer’s, experts claim
DITCHING junk food could stave off dementia, experts have claimed.
They found over-60s who eat healthily are less likely to get Alzheimer’s.
Experts claim that ditching junk food could stave off dementia[/caption]
Playing card games and meeting friends or family twice a week also helps.
Researchers tracked lifestyles of 29,000 adults for ten years and checked for the APOE gene associated with Alzheimer’s.
Fruit, veg, fish, meat, dairy, salt, oil, eggs, cereals, legumes, nuts and tea had the strongest effect on slowing the disease.
That was followed by writing, reading, playing games and physical exercise.
People with the APOE gene who had healthy lives experienced a slower rate of decline.
Jianping Jia, of China’s Capital Medical University in Beijing, said: “These results might offer important information for initiatives to protect older adults against decline.”
Eli Lilly shares fall 3% after hours as FDA rejects submission for Alzheimer’s treatment
Brett Arends’s ROI: Eating these simple foods may slow Alzheimer’s by a third
Biogen, Eisai’s lecanemab gets Alzheimer’s nod, but how successful it will be is uncertain
FDA Approves New Alzheimer’s Drug, but There Are Lingering Questions
The Food and Drug Administration on Friday granted the conditional approval of a new treatment for people with early Alzheimer’s disease: the antibody-based drug lecanemab, jointly developed by the pharmaceutical companies Biogen and Eisai. In a large trial, lecanemab appeared to slow down patients’ cognitive decline…
Researchers develop blood test that can reliably detect Alzheimer’s disease
When doctors need to confirm an Alzheimer’s diagnosis, they often turn to a combination of brain imaging and cell analysis. Both have their downsides. The latter involves a lumbar puncture, an invasive and painful procedure that’s more commonly known as a spinal tap. A doctor will insert a needle into the lower back to extract a sample of the patient’s cerebrospinal fluid. A lab technician then tests the sample for signs of progressive nerve cell loss and excessive amyloid and tau protein accumulation. MRI scans are less invasive but they’re often expensive and accessibility is an issue; not every community has access to the technology.
The next best tool for diagnosing Alzheimer’s disease is a blood test. While some can detect abnormal tau protein counts, they’re less effective at spotting the telltale signs of neurodegeneration. But that could soon change. This week, in the journal Brain, a multinational team made up of researchers from Sweden, Italy, the UK and US detailed a new antibody-based blood test they recently developed. The new test can detect brain-derived tau proteins, which are specific to Alzheimer’s disease. Following a study of 600 patients, the team found their test could reliably distinguish the illness from other neurodegenerative diseases.
Dr. Thomas Karikari, a professor of psychiatry at the University of Pittsburgh and one of the co-authors of the study, told The Guardian he hopes the breakthrough could help other researchers design better clinical trials for Alzheimer’s treatments. “A blood test is cheaper, safer and easier to administer, and it can improve clinical confidence in diagnosing Alzheimer’s and selecting participants for clinical trial and disease monitoring,” he said. There’s more work to be done before the test makes its way to your local hospital. To start, the team needs to validate that it works for a wide variety of patients, including those who come from different ethnic backgrounds.